Fiasp and the Onset 5 CSII Trial – What Novo Nordisk found
Around the time of launching Fiasp, Novo Nordisk embarked on a wider study of its use in Continuous Subcutaneous Insulin Infusion (CSII), or pumping as […]
Month: August 2018
Nemaura Sugarbeat’s interim home trial results. Are they any good?
Over the past eight months, Nemaura have announced a number of outcomes of their clinical trials, all of which have suggested that after a tricky […]